DISCOVERIES REPORTS (ISSN 2393249X), 2022, volume 5

REVIEW ARTICLE

FULL text (PDF) - coming soon

GO BACK to 2022, VOLUME 5

CITATION: Dindere ME, Bucur O. Cancer detection during surgery: FDA-approved use of pafolacianine. Discoveries Reports 2022; 5(2): e30. DOI: 10.15190/drep.2022.4

Cancer detection during surgery: FDA-approved use of pafolacianine

Mihaela Elisabeta Dindere1,2, Octavian Bucur1,3,*

1Victor Babes National Institute of Pathology, Bucharest, Romania
2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
3Viron Molecular Medicine Institute, Boston, MA, USA

* Corresponding author: Octavian Bucur, MD, PhD, Next Generation Pathology Group, Victor Babes National Institute of Pathology, Bucharest, Romania and Viron Molecular Medicine Institute, Boston, MA 02108, USA; octavian.bucur@ivb.ro; octavian.bucur@gmail.com

Access FULL text of the manuscript here: FULL ARTICLE (PDF) - coming soon